We verified that our results in iMEFs were also representative of lymphoma by assessing the transcriptomic effects of PRC2 inhibition in EZH2-WT and EZH2Y646F-expressing OCI-Ly19 cells29. The gene discussed is EZH2; the disease is lymphoma.